The work of the African Research Group for Oncology (ARGO) and its collaborators has received international attention in a recent CNN feature examining the growing burden of colorectal cancer in
-> Continue reading CNN Highlights ARGO’s Efforts to Improve Colorectal Cancer Detection and Care in Nigeria
Click here to register for the upcoming 2026 ARGO Symposium Click here to download the Symposium Flyer
ARGO 2025 SYMPOSIUM Theme: From Screening to Survivorship: A Multidisciplinary Approach to the Management of Breast, Cervical, Colorectal, and Hepatobiliary Cancers in Nigeria Date: Wednesday 24th – Thursday 25th, September,
-> Continue reading ARGO 2025 Symposium Information
Schedule of Events and Brochure Click here to download the brochure and schedule of events.
Program Description The African Research Group for Oncology (a National Cancer Institute-approved Colorectal Cancer Consortium) and the Global Cancer Disparity Initiative at Memorial Sloan Kettering Cancer Centre, New York, in
-> Continue reading 2025 Global Gastrointestinal Medical Oncology Fellowship Program
This capacity-building training aims to increase the number of healthcare professionals skilled in performing colonoscopies and improve outcomes for colorectal cancer patients in Nigeria. The African Research Group for Oncology
-> Continue reading 2025 Colonoscopy Training and Registration
ARGO and GCRT Leadership Visits Prof. Christian Happi at Redeemer’s University on Partnerships in Cancer Genomics
This year’s symposium, the eighth in the series, assembles a team of leading local and international experts to give up-to-date information and hands-on training in various aspects of colorectal, breast,
-> Continue reading ARGO in collaboration with MSKCC USA Holds a 2-Day Symposium Themed “Integrating Evidence and Innovation In Addressing Cancer Care Challenges In Nigeria”
There is a paucity of prospective data on the performance of the fecal immunochemical test (FIT) for colorectal cancer (CRC) screening in sub-Saharan Africa. The aim of this exploratory analysis was to evaluate the feasibility and performance of FIT in Nigeria.
There is a paucity of prospective data on the performance of the fecal immunochemical test (FIT) for colorectal cancer (CRC) screening in sub-Saharan Africa. The aim of this exploratory analysis was to evaluate the feasibility and performance of FIT in Nigeria.